Амбулатория За Специализирана Извънболнична Медицинска Помощ Ревматологичен Център Света Ирина ЕООD

The research site is advancing treatments for psoriatic arthritis, an inflammatory condition that affects both skin and joints, by testing new biologic agents and small‑molecule inhibitors. Studies aim to improve symptom control, reduce joint damage, and offer alternatives for patients who do not respond to existing anti‑TNF therapies.

• Therapeutic equivalence studies of biosimilar agents
• Evaluation of novel biologics in anti‑TNF‑experienced patients
• Assessment of JAK inhibitor efficacy and safety
• Management strategies for inadequate responders

At the Амбулатория За Специализирана Извънболнична Медицинска Помощ Ревматологичен Център Света Ирина ЕООД, investigators are collaborating with international sponsors to bring innovative immune‑modulating therapies to the Bulgarian patient community.

Clinical investigations at the center focus on post‑menopausal osteoporosis, targeting bone loss in older women. Trials compare a new bisphosphonate biosimilar with an established treatment to confirm similar improvements in bone mineral density and reductions in bone turnover markers.

• Bone mineral density improvement studies
• Serum C‑telopeptide (sCTX) monitoring for bone resorption
• Safety and immunogenicity evaluation of biosimilar agents
• Comparative effectiveness of osteoporosis therapies

The Sofia‑based clinic leverages its expertise in musculoskeletal health to provide patients access to cutting‑edge osteoporosis research and potential new treatment options.